Cargando…

PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma

BACKGROUND: Cervical small cell neuroendocrine carcinoma (SCNC) is a rare and aggressive disease that lacks a standard treatment strategy or effective methods of targeted therapy. PD-L1 inhibitors for DNA mismatch repair system-deficient (dMMR) tumors and neurotrophin receptor tyrosine kinase (NTRK)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Longyun, Yang, Fan, Feng, Ting, Wu, Shafei, Li, Kaimi, Pang, Junyi, Shi, Xiaohua, Liang, Zhiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566736/ https://www.ncbi.nlm.nih.gov/pubmed/34745983 http://dx.doi.org/10.3389/fonc.2021.752453

Ejemplares similares

Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma
por: Wu, Shafei, et al.
Publicado: (2021)

Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma
por: Liu, Hangqi, et al.
Publicado: (2022)

DNA Mismatch Repair Deficiency Detection in Colorectal Cancer by a New Microsatellite Instability Analysis System
por: Wu, Shafei, et al.
Publicado: (2020)

Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
por: Svensson, Maria C., et al.
Publicado: (2019)

Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3
por: Wu, Shafei, et al.
Publicado: (2021)

NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance
por: Liu, Fangfang, et al.
Publicado: (2022)

MRVI1 and NTRK3 Are Potential Tumor Suppressor Genes Commonly Inactivated by DNA Methylation in Cervical Cancer
por: Ji, Huihui, et al.
Publicado: (2022)

Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma
por: Yu, Qing-Xiang, et al.
Publicado: (2023)

Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases
por: Zhang, Qingfu, et al.
Publicado: (2021)

BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations
por: Deihimi, Safoora, et al.
Publicado: (2017)

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
por: Wang, Yuekun, et al.
Publicado: (2020)

The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis
por: Guan, Wen-Long, et al.
Publicado: (2021)

A Rapid, Simple DNA Mismatch Repair Substrate Construction Method
por: Du, Weinan, et al.
Publicado: (2011)

Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
por: Rasmussen, Maria, et al.
Publicado: (2023)

Should immunohistochemical expression of mismatch repair (MMR) proteins and microsatellite instability (MSI) analysis be routinely performed for poorly differentiated colorectal neuroendocrine carcinomas?
por: Luong, Tu Vinh, et al.
Publicado: (2020)

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors
por: Sigal, Darren S., et al.
Publicado: (2018)

Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
por: Li, Xiaoying, et al.
Publicado: (2023)

Computed Tomography Features of Gastric Cancer Patients With DNA Mismatch Repair Deficiency
por: Cao, Qian, et al.
Publicado: (2021)

Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma
por: Sung, You-Na, et al.
Publicado: (2021)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
por: Song, Yurong, et al.
Publicado: (2023)

The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance
por: Feng, Yang-chun, et al.
Publicado: (2018)

Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
por: Ren, Xin-yu, et al.
Publicado: (2021)

Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia
por: Han, Su Jin, et al.
Publicado: (2015)

PD-L1 expression in lung adenosquamous carcinomas compared with the more common variants of non-small cell lung cancer
por: Shi, Xiaohua, et al.
Publicado: (2017)

Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions
por: Dai, Yinghuan, et al.
Publicado: (2022)

Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor
por: Chen, Yanming, et al.
Publicado: (2022)

Clinical Characterization of Mismatch Repair Gene-Deficient Metastatic Castration-Resistant Prostate Cancer
por: Ye, Senlin, et al.
Publicado: (2020)

The Frequency of DNA Mismatch Repair Deficiency Is Very Low in Surgically Resected Lung Carcinoma
por: Yanagawa, Naoki, et al.
Publicado: (2021)

Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
por: Király, Zsófia, et al.
Publicado: (2022)

Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer
por: Kim, Yoo-Na, et al.
Publicado: (2023)

MiRNA-128-3p Restrains Malignant Melanoma Cell Malignancy by Targeting NTRK3
por: Zhou, Xinxin, et al.
Publicado: (2021)

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
por: Ghandili, Susanne, et al.
Publicado: (2023)

Immunohistochemical mismatch repair proteins expression as a tool to predict the melanoma immunotherapy response
por: Ponti, Giovanni, et al.
Publicado: (2020)

Routine Immunohistochemical Analysis of Mismatch Repair Proteins in Colorectal Cancer—A Prospective Analysis
por: Lemos Garcia, Joana, et al.
Publicado: (2022)

CT-based radiomic nomogram for preoperative prediction of DNA mismatch repair deficiency in gastric cancer
por: Zeng, Qingwen, et al.
Publicado: (2022)

Clinicopathological characteristics and loss of mismatch repair protein expression in Chinese upper tract urothelial carcinomas
por: Shang, Zhi, et al.
Publicado: (2022)

Deficient Mismatch Repair Proteins in Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasm: A Rare Case Report
por: Nguyen, Thi Hong Chuyen, et al.
Publicado: (2023)

Case Report: An NTRK1 fusion-positive embryonal rhabdomyosarcoma: clinical presentations, pathological characteristics and genotypic analyses
por: Li, Na-Mei, et al.
Publicado: (2023)

Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer
por: Moriyama, Etsuko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l0alhopsslbjc2ced0gnco0ri7